Financhill
Sell
33

ESEA Quote, Financials, Valuation and Earnings

Last price:
$34.06
Seasonality move :
9.82%
Day range:
$32.95 - $34.66
52-week range:
$30.78 - $50.92
Dividend yield:
7.01%
P/E ratio:
2.11x
P/S ratio:
1.14x
P/B ratio:
0.70x
Volume:
61.6K
Avg. volume:
48.7K
1-year change:
11.83%
Market cap:
$240M
Revenue:
$189.4M
EPS (TTM):
$16.22
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $40M $53.3M $93.9M $182.7M $189.4M
Revenue Growth (YoY) 16.26% 33.18% 76.15% 94.58% 3.65%
 
Cost of Revenues $31.9M $40.7M $41.7M $68.2M $69.5M
Gross Profit $8.1M $12.6M $52.2M $114.5M $119.9M
Gross Profit Margin 20.22% 23.65% 55.63% 62.69% 63.3%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.1M $8.3M $7.8M $9.5M $10.5M
Other Inc / (Exp) -$329.2K $1.2M -$2.1K $4.4M $7.5M
Operating Expenses $6.1M $5.6M $6.5M $7.9M $7.7M
Operating Income $2M $7M $45.7M $106.6M $112.1M
 
Net Interest Expenses $3.3M $4.1M $2.8M $4.8M $5M
EBT. Incl. Unusual Items -$1.7M $4M $43M $106.2M $114.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$1.7M $4M $43M $106.2M $114.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.7M $4M $43M $106.2M $114.5M
 
Basic EPS (Cont. Ops) -$1.21 $0.58 $6.07 $14.79 $16.53
Diluted EPS (Cont. Ops) -$1.21 $0.58 $6.06 $14.78 $16.52
Weighted Average Basic Share $2.9M $5.8M $7M $7.2M $6.9M
Weighted Average Diluted Share $2.9M $5.8M $7M $7.2M $6.9M
 
EBITDA $5.9M $14.8M $52.9M $129.8M $143.8M
EBIT $1.7M $8.2M $45.7M $111.3M $121M
 
Revenue (Reported) $40M $53.3M $93.9M $182.7M $189.4M
Operating Income (Reported) $2M $7M $45.7M $106.6M $112.1M
Operating Income (Adjusted) $1.7M $8.2M $45.7M $111.3M $121M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $12.3M $23M $46M $50.7M $54.1M
Revenue Growth (YoY) 19.71% 86.89% 99.46% 10.25% 6.87%
 
Cost of Revenues $10.3M $12.2M $19M $17.4M $20.1M
Gross Profit $2.1M $10.8M $26.9M $33.2M $34.1M
Gross Profit Margin 16.84% 47.02% 58.61% 65.6% 62.92%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.1M $1.8M $2.2M $2.4M $3.4M
Other Inc / (Exp) $1.2M $48.6K $1.8M $2.5M -$466.7K
Operating Expenses $2.1M $1.8M $2.2M $2.1M $3.4M
Operating Income -$17.5K $9M $24.7M $31.1M $30.7M
 
Net Interest Expenses $927.5K $620.4K $1.3M $1.4M $2.6M
EBT. Incl. Unusual Items $218.9K $8.5M $25.2M $32.2M $27.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $218.7K $8.5M $25.2M $32.2M $27.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $218.9K $8.5M $25.2M $32.2M $27.6M
 
Basic EPS (Cont. Ops) $0.01 $1.18 $3.50 $4.67 $3.97
Diluted EPS (Cont. Ops) $0.01 $1.17 $3.50 $4.65 $3.95
Weighted Average Basic Share $5.7M $7.2M $7.2M $6.9M $7M
Weighted Average Diluted Share $5.7M $7.2M $7.2M $6.9M $7M
 
EBITDA $2.8M $10.7M $31.9M $40M $37.6M
EBIT $1.1M $9.1M $26.6M $34M $30.9M
 
Revenue (Reported) $12.3M $23M $46M $50.7M $54.1M
Operating Income (Reported) -$17.5K $9M $24.7M $31.1M $30.7M
Operating Income (Adjusted) $1.1M $9.1M $26.6M $34M $30.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $54.6M $67.7M $178.1M $183.2M $208.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $42.7M $39M $59.7M $70.5M $82.3M
Gross Profit $11.9M $28.7M $118.4M $112.7M $126.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8M $7.5M $8.9M $9.1M $10.4M
Other Inc / (Exp) $570.8K $1M $3.8M $8.6M $5.3M
Operating Expenses $5.3M $6.2M $9.2M $6.8M $11M
Operating Income $6.6M $22.5M $109.1M $105.9M $115.4M
 
Net Interest Expenses $4.5M $2.8M $4.2M $4.4M $7.5M
EBT. Incl. Unusual Items $2.7M $20.8M $108.7M $110.2M $113.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $2.7M $20.8M $108.7M $110.2M $113.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.7M $20.8M $108.7M $110.2M $113.1M
 
Basic EPS (Cont. Ops) $0.35 $2.90 $15.05 $15.82 $16.33
Diluted EPS (Cont. Ops) $0.35 $2.88 $15.00 $15.76 $16.22
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $13.7M $30M $128.5M $137.9M $147.7M
EBIT $7.2M $23.6M $112.9M $115.7M $122.7M
 
Revenue (Reported) $54.6M $67.7M $178.1M $183.2M $208.6M
Operating Income (Reported) $6.6M $22.5M $109.1M $105.9M $115.4M
Operating Income (Adjusted) $7.2M $23.6M $112.9M $115.7M $122.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $41.3M $55.6M $139.8M $140.3M $159.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $31.4M $29.7M $47.7M $50.1M $62.9M
Gross Profit $9.8M $25.9M $92.1M $90.2M $96.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.3M $5.4M $6.5M $6.1M $7.4M
Other Inc / (Exp) $576.7K $419.8K $4.2M $8.4M $6.2M
Operating Expenses $3.6M $4.1M $6.9M $5.8M $9M
Operating Income $6.2M $21.8M $85.2M $84.4M $87.7M
 
Net Interest Expenses $3.3M $2M $3.5M $3M $5.5M
EBT. Incl. Unusual Items $3.5M $20.2M $85.9M $89.8M $88.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $3.5M $20.2M $85.9M $89.8M $88.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.5M $20.2M $85.9M $89.8M $88.4M
 
Basic EPS (Cont. Ops) $0.53 $2.83 $11.91 $12.95 $12.75
Diluted EPS (Cont. Ops) $0.53 $2.81 $11.87 $12.90 $12.66
Weighted Average Basic Share $16.9M $20.7M $21.6M $20.8M $20.8M
Weighted Average Diluted Share $16.9M $20.8M $21.7M $20.9M $20.9M
 
EBITDA $11.8M $27M $102.6M $110.6M $114.4M
EBIT $6.8M $22.2M $89.4M $93.7M $95.5M
 
Revenue (Reported) $41.3M $55.6M $139.8M $140.3M $159.6M
Operating Income (Reported) $6.2M $21.8M $85.2M $84.4M $87.7M
Operating Income (Adjusted) $6.8M $22.2M $89.4M $93.7M $95.5M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $985.4K $3.6M $26.5M $25.8M $58.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $715.1K $2M $1.3M $573K $2M
Inventory $1.9M $1.7M $2.3M $2.3M $2.5M
Prepaid Expenses $526.5K $244.3K $382.7K $350.2K $502.8K
Other Current Assets -- -- -- -- --
Total Current Assets $6.3M $9.7M $32.9M $46.9M $66M
 
Property Plant And Equipment $116.2M $98.5M $183.7M $275.7M $353M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $4.3M $2.4M $4.8M $3.4M $5.7M
Total Assets $126.9M $110.6M $221.4M $328.6M $424.7M
 
Accounts Payable $3.9M $2.9M $2.8M $5.2M $5.7M
Accrued Expenses $1.7M $1.3M $1.7M $1.8M $1.9M
Current Portion Of Long-Term Debt $17.3M $23.1M $29M $55.4M $30.8M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- $203.6K -- $3.6M $56K
Total Current Liabilities $24.9M $28.6M $37.1M $73.7M $51.2M
 
Long-Term Debt $72.2M $46.2M $89M $51.8M $99.2M
Capital Leases -- -- -- -- --
Total Liabilities $98.8M $83.2M $144.6M $160.4M $158.1M
 
Common Stock $7.8M $201.3K $218.8K $213.5K $210.4K
Other Common Equity Adj -- -- -- -- --
Common Equity $20.5M $27.3M $76.9M $168.2M $266.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $28.1M $27.3M $76.9M $168.2M $266.6M
 
Total Liabilities and Equity $126.9M $110.6M $221.4M $328.6M $424.7M
Cash and Short Terms $985.4K $3.6M $26.5M $25.8M $58.6M
Total Debt $89.5M $69.4M $118M $107.2M $130M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $2.3M $5.9M $27.4M $48.3M $77.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.1M $1.7M $584.3K $1.6M $3.1M
Inventory $2.2M $1.7M $2.4M $2.7M $3.1M
Prepaid Expenses $300.2K $444.8K $636.1K $855.9K $956.9K
Other Current Assets -- -- -- -- --
Total Current Assets $7.7M $10.9M $33.9M $62.8M $87.4M
 
Property Plant And Equipment $103.1M $104.6M $280.6M $340M $486.5M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.3M $4.2M $5.4M $5.7M $6.9M
Total Assets $113.1M $120M $321.7M $408.9M $580.9M
 
Accounts Payable $2.7M $3M $4.6M $3.7M $4M
Accrued Expenses $1.5M $2.2M $3.5M $2.3M $5.2M
Current Portion Of Long-Term Debt $14.4M $14.8M $39.8M $29M $37.6M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $336.4K $277.1K -- -- --
Total Current Liabilities $19.9M $21.6M $54.5M $46.8M $53M
 
Long-Term Debt $60.6M $44.4M $75.1M $108.2M $180.4M
Capital Leases -- -- -- -- --
Total Liabilities $80.9M $66M $168.5M $163.8M $237.5M
 
Common Stock $8.2M $217.4K $214.9K $208.6K $210.4K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $32.2M $54M $153.2M $245.1M $343.4M
 
Total Liabilities and Equity $113.1M $120M $321.7M $408.9M $580.9M
Cash and Short Terms $2.3M $5.9M $27.4M $48.3M $77.3M
Total Debt $75M $59.2M $114.9M $137.3M $218M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$1.7M $4M $43M $106.2M $114.5M
Depreciation & Amoritzation $4.2M $6.6M $7.2M $18.5M $22.8M
Stock-Based Compensation $97.9K $121.6K $182.3K $951.4K $1.1M
Change in Accounts Receivable $704.5K -$1.3M $882K -$3.1M $1.8M
Change in Inventories -$184.8K $226.7K -$612K -$31.7K $178.1K
Cash From Operations $3.2M $2.4M $52.6M $114.1M $130M
 
Capital Expenditures $55.7M $647.1K $74.1M $90.7M $112.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$55.7M $16.3M -$74.1M -$87.1M -$102.2M
 
Dividends Paid (Ex Special Dividend) -$1M -$320.9K -$424K -$10.8M -$14M
Special Dividend Paid
Long-Term Debt Issued $65.2M -- $75.5M $19.3M $92M
Long-Term Debt Repaid -$13.4M -$18.5M -$26.3M -$30.3M -$69M
Repurchase of Common Stock -$11.7M -- -$2M -$5M -$3.1M
Other Financing Activities -$703.2K -$184.3K -$881.2K -$143.1K -$833.9K
Cash From Financing $45.2M -$18.3M $46.6M -$27M $5.1M
 
Beginning Cash (CF) $13.2M $5.9M $6.3M $31.5M $31.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$7.3M $408.1K $25.2M -$59.7K $32.9M
Ending Cash (CF) $5.9M $6.3M $31.5M $31.4M $64.3M
 
Levered Free Cash Flow -$52.5M $1.8M -$21.5M $23.4M $17.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $218.7K $8.5M $25.2M $32.2M $27.6M
Depreciation & Amoritzation $1.6M $1.6M $5.3M $5.9M $6.7M
Stock-Based Compensation $30.7K $15.8K $219.3K $141K $359.5K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$2.3M $12.6M $31.3M $31.1M $33.5M
 
Capital Expenditures $195.4K $10.6M $13M $15.8M $33.1M
Cash Acquisitions -- -- -- -- --
Cash From Investing $11.2M -$10.6M -$13M -$15.8M -$33.1M
 
Dividends Paid (Ex Special Dividend) -- -$332.4K -$3.6M -$3.5M -$4.2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $10M $19.3M $40M $20.4M
Long-Term Debt Repaid -$8.8M -$12.3M -$8.8M -$34.5M -$8.4M
Repurchase of Common Stock -- -- -$2.6M -$938.6K --
Other Financing Activities -$360 -$234.5K -$115.5K -$296K -$167.8K
Cash From Financing -$8.1M -$2.9M $4.2M $777.9K $7.6M
 
Beginning Cash (CF) $3.9M $11M $10.5M $38.2M $76.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $908.8K -$802.2K $22.5M $16.1M $8M
Ending Cash (CF) $4.8M $10.2M $33M $54.4M $84.3M
 
Levered Free Cash Flow -$2.5M $2.1M $18.3M $15.4M $399.3K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.7M $20.8M $108.7M $110.2M $113.1M
Depreciation & Amoritzation $6.5M $6.4M $15.6M $22.2M $24.9M
Stock-Based Compensation $117.1K $103.8K $759.5K $1.1M $1.3M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $2M $27.4M $121.2M $109.7M $131.9M
 
Capital Expenditures $41M $11M $143.6M $104.5M $176.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$29M -$6M -$143.6M -$90.8M -$166.2M
 
Dividends Paid (Ex Special Dividend) -$482.2K -$424K -$7.2M -$14M -$16.1M
Special Dividend Paid
Long-Term Debt Issued -- -- $84.8M $92M $114.4M
Long-Term Debt Repaid -$16.6M -$23.9M -$28.8M -$69.4M -$32.7M
Repurchase of Common Stock -- -$2M -$2.9M -$5.3M --
Other Financing Activities -$529.6K -$438.4K -$729.6K -$833.7K -$1.4M
Cash From Financing $24.5M -$16M $45.1M $2.5M $64.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.6M $5.4M $22.7M $21.4M $29.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$39M $16.4M -$22.4M $5.2M -$44.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $3.5M $20.2M $85.9M $89.8M $88.4M
Depreciation & Amoritzation $5M $4.8M $13.2M $16.8M $18.9M
Stock-Based Compensation $91.5K $73.7K $650.8K $821.3K $1.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.7M $26.7M $95.3M $90.9M $92.9M
 
Capital Expenditures $451.9K $10.8M $80.3M $94.1M $158.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing $11.5M -$10.8M -$80.3M -$84M -$148M
 
Dividends Paid (Ex Special Dividend) -$320.9K -$424K -$7.2M -$10.5M -$12.5M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $10M $19.3M $92M $114.4M
Long-Term Debt Repaid -$14.7M -$20.1M -$22.6M -$61.6M -$25.4M
Repurchase of Common Stock -- -$2M -$2.9M -$3.1M --
Other Financing Activities -$40.9K -$294.9K -$143.3K -$833.9K -$1.4M
Cash From Financing -$14.3M -$12M -$13.6M $15.9M $75.1M
 
Beginning Cash (CF) $15.3M $23.8M $96.1M $103.5M $196M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.1M $3.9M $1.5M $22.9M $20M
Ending Cash (CF) $14.2M $27.7M $97.6M $126.4M $216M
 
Levered Free Cash Flow $1.3M $15.9M $15.1M -$3.1M -$65.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock